Long-term outcome on kidney retransplantation: a review of 100 cases from a single center

Transplant Proc. 2009 May;41(4):1156-8. doi: 10.1016/j.transproceed.2009.03.083.


Renal transplantation has become an effective form of treatment for end-stage renal failure. Unfortunately, as a consequence of immunological and nonimmunological pathogenic mechanisms, chronic allograft nephropathy is responsible for the loss of a large proportion of kidney grafts after several years and return to dialysis. We have reported herein our 24 years of experience with second kidney transplantations. Of 1,302 kidney transplantations between January 1983 and June 2007 performed in our transplantation center, 100 were second transplantations. Kidney retransplantation was performed in 74 men and 26 women of overall mean age of 35.4 +/- 12.6 years. Cadaveric donor grafts were transplanted in 92 patients, whereas the remaining 8 were living-related donor kidneys. At 1, 5, and 10 years after kidney transplantation, patient survival rates were 100%, 96%, and 92%, respectively, whereas graft survival rates were 85%, 72%, and 53%, respectively. Immunosuppressive therapy included induction therapy with polyclonal anti-lymphocyte antibodies (ALG/ATG) or (starting from 1999) monoclonal anti CD 25 antibody. Our results demonstrated good outcomes for kidney retransplantations with allocation based on anti- HLA antibody identification together with induction immunosuppression.

MeSH terms

  • Adult
  • Cadaver
  • Female
  • Graft Survival
  • Humans
  • Italy / epidemiology
  • Kidney Transplantation / mortality*
  • Living Donors / statistics & numerical data
  • Male
  • Renal Dialysis / statistics & numerical data
  • Reoperation / statistics & numerical data
  • Survival Rate
  • Tissue Donors